|
---|
Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] Category:Map
MONTHYEARML19323E5072019-11-27027 November 2019 Letter to D. Penkiunas Request for Scoping Comments Concerning the Shine Medical Isotope Production Facility Application Review ML19323E2882019-11-27027 November 2019 Letter to R. Nelson Request for Scoping Comments Concerning the Shine Medical Isotope Production Facility Application Review ML13135A3042013-07-0101 July 2013 Letter Request for Scoping Comments on the Shine Medical Technologies Radioisotope Production Facility Environmental Review ML13135A6352013-07-0101 July 2013 Shine Medical Technologies Radioisotope Production Facility Application Review ML13149A5202013-07-0101 July 2013 Enclosures to Fws and Wdnr Scoping Letters for Shine ML13135A6432013-07-0101 July 2013 Enclosures to Shpo and Achp Scoping Letters for Shine ML13309B6312010-12-31031 December 2010 Shine Medical Technologies, Inc. Application for Construction Permit Response to Environmental Requests for Additional Information, Enclosure 2, Attachment 34 - Janesville (Lower) 2010 Traffic Counts 2019-11-27
[Table view] |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 27, 2019 Mr. Reid Nelson, Director Office of Federal Agency Programs Advisory Council on Historic Preservation 401 F Street NW, Suite 308 Washington, DC 20001-2637
SUBJECT:
REQUEST FOR SCOPING COMMENTS CONCERNING THE SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE (DOCKET NUMBER: 50-608)
Dear Mr. Nelson:
The U.S. Nuclear Regulatory Commission (NRC) received an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. The application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) Part 50. This facility would be located approximately 4 miles south of Janesville, Rock County, Wisconsin (see Enclosure
- 1) and if licensed, would produce radioisotopes for use in diagnostic medical procedures.
A review was conducted for the construction permit from 2013 - 2015. As a result of this review, the NRC issued Construction Permit Number CPMIF-001 to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession Number ML16041A473). The review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016, (ADAMS Accession Number ML16229A140) and NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ADAMS Accession Number ML15288A046).
In connection with issuance of an operating license for a production or utilization facility, the NRC is required to supplement the final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final EIS or that reflect significant new information concerning matters discussed in the final EIS. Therefore, the NRC staff will prepare a supplement to NUREG-2183 under 10 CFR Part 51, NRC's regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA).
R. Nelson 2 In accordance with 36 CFR 800.8(c), the NRC intends to comply with Section 106 of the National Historic Preservation Act of 1966, as amended, through the NEPA process.
Accordingly, the NRC staff is inviting parties who may be interested in the proposed action to consult with the NRC staff on this matter. Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area at the proposed site and its immediate environs [see Enclosure 2]).
Please submit any comments that you may have on the scope of the environmental review by January 13, 2020. Written comments should be submitted by mail to:
Program Management, Announcements and Editing Staff Office of Administration Mailstop TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555 Electronic comments may be submitted to the NRC by accessing www.regulations.gov and searching for Docket ID NRC-2019-0173.
The NRC accepted the SHINE operating license application for review on October 8, 2019.
The application is available through the web-based version of ADAMS, which is accessible at http://www.nrc.gov/reading-rm/adams.html. The ADAMS Accession Number for the SHINE operating license application is ML19211C143. The ADAMS Accession Number supplemental environmental report SHINE operating license application is ML19211C139.
The NRC staff plans to hold a public environmental scoping meeting on December 12, 2019, at The Celtic House at Glen Erin Golf Club, 1417 W. Airport Road, Janesville, Wisconsin, 53546. The meeting will convene at 6:00 p.m. and will continue until 8:00 p.m.,
as necessary. Prior to the meeting, the NRC staff will hold an open house beginning at 5:00 p.m. to discuss the proposed action with interested stakeholders. The NRC staff expects to publish the draft supplement in 2020. A copy of the supplement will be made available for your review and comment.
R. Nelson 3 If you have any questions concerning the NRC staff's review of this operating license application, please contact Mr. Robert Hoffman, Environmental Scientist, at 301-415-1107 or via e-mail at Robert.Hoffman@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosures:
- 1. Area Map, 6-mile radius
- 2. Aerial View of the SHINE Site
ML19323E288 *via email OFFICE NMSS/REFS/EMRB NMSS/REFS/ELRB NMSS/REFS/ENRB NMSS/REFS/ENRB NMSS/REFS/ELRB NAME *AWalker-Smith *RHoffman *JDavis *NMartinez RElliott DATE 11/20/2019 11/22/2019 11/22/2019 11/22/2019 11/27/2019
- Area Map, 6-mile radius : Aerial View of the SHINE Site